Introduction {#s1}
============

Salamanders are the only vertebrates known to regenerate complete limbs as adults. The axolotl, a species of salamander, can regenerate limbs, tails, and gills without scarring. Regeneration of these complex structures occurs through the formation of a blastema, a mass of proliferating dedifferentiated cells and pre-existing progenitor and stem cells ([@bib3]; [@bib22]; [@bib30]). Transcriptional profiling of the limb blastema has produced long lists of candidate genes that, to date, remain largely uncharacterized ([@bib1]; [@bib2]; [@bib15]; [@bib21]; [@bib23]; [@bib26]; [@bib41]).

The advent of CRISPR/Cas9 has made the axolotl a genetically tractable organism and the functional interrogation of these genes possible ([@bib10]; [@bib8]). Although near-complete knockout F~0~ animals can be generated, they appear to be universally mosaic, harboring a variety of mutant alleles ([@bib10]). Such embryonically generated mutations both perturb the function of the targeted gene and uniquely label affected cell lineages with a traceable genetic barcode. Previously, we measured the fidelity of limb regeneration by using next-generation sequencing (NGS) to quantify the mutant allele frequencies of multiple genomic loci before and after limb regeneration in mosaic mutant axolotls ([@bib11]). We found that the majority of very low-frequency alleles reoccur in a regenerated limb at a frequency strikingly similar to that of the original limb. These data indicate that limb regeneration is a high-fidelity process in which the contributions of small cell populations to the original limb are replicated in the regenerated limb ([Figure 1C,D](#fig1){ref-type="fig"}).

![Haploid-diploid chimeric generation and lineage analysis.\
(**A**) Schematic of haploid-diploid chimera generation. Gynogenetic haploids are generated by in vitro activation of unfertilized eggs with UV-enucleated sperm and subsequently mutagenized using CRISPR/Cas9. Chimeric embryos are generated by replacing the limb buds of GFP+ diploid embryos with corresponding tissue from mutagenized haploid donors. (**B**) DNA is extracted from original and fully regenerated haploid limbs of juvenile chimeric axolotls, target sequences are PCR amplified, and these products are subjected to NGS. (**C**) Schematic depicting the contribution of mutant cell lineages to the original and regenerated limb. Cell lineages mutant for non-essential candidate genes (light blue, dark blue, yellow, purple, red, green) may participate normally in regeneration and therefore contribute to the regenerated limb and original limb in a similar proportion. Cell lineages harboring deleterious mutant alleles deleterious (red, far right) are predicted to be reduced in regenerated limbs. (**D**) A hypothetical linear regression plot of the log~2~ of reads per ten thousand (RP10K+1) of mutant alleles before and after regeneration. Mutant alleles of a neutral gene, tyrosinase (blue), are faithfully preserved between original and regenerated limbs. Mutagenized genes essential for regeneration (red) will show a decrease in allele frequency or a complete loss of alleles in the regenerated limb.](elife-48511-fig1){#fig1}

Recent single-cell sequencing of the axolotl limb blastema demonstrated that cell identities converge at a transcriptional level during regeneration ([@bib15]). This suggests a shared genetic program across most blastemal cells. We anticipated that genetic perturbation of critical blastema-enriched genes would impair mutagenized cells' ability to participate in the regenerative process. Negative selection screens are widely used to identify genes essential for cellular processes with CRISPR/Cas ([@bib35]; [@bib42]; [@bib43]). Screening can be improved by using haploid cells, which harbor a single copy of each gene, and thus require monoallelic inactivation to unveil loss-of-function phenotypes. We sought to determine whether we could detect negative selection of mutant alleles in regenerated haploid limbs of axolotls. ([Figure 1C,D](#fig1){ref-type="fig"}).

Results {#s2}
=======

We generated gynogenetic haploids through in vitro activation of eggs from *white* or transgenic RFP+ females using UV-enucleated sperm from a transgenic GFP+ male ([Figure 1A,B](#fig1){ref-type="fig"}). Haploidy was confirmed by karyotype (n = 14, 3/3 embryos, three squashes/embryo, [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), the universal appearance of the haploid syndrome embryonic phenotype (120/120 embryos, [Figure 2---figure supplement 1B,C](#fig2s1){ref-type="fig"}; [@bib17]), and complete absence of paternally-derived GFP expression in donor embryos (156/156 GFP-, [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). Adult haploid axolotls are not viable, so we developed reliable whole limb bud grafting techniques to generate chimeric axolotls with haploid limbs ([Figure 1A](#fig1){ref-type="fig"}, [Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}). To find the optimal embryonic stage for limb bud grafting, we performed reciprocal grafts between stage-matched *white* and GFP+ diploid embryos across a range of developmental stages ([Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}). Diploid-diploid chimera (DDC) graft limbs were scored for the presence or absence of GFP+ host-derived cells using a fluorescent microscope. Embryos grafted at stage 23--25 produced normally developed limbs with a consistent host-derived neural GFP+ expression pattern ([Figure 2B](#fig2){ref-type="fig"}; [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}). We adapted the DDC grafting protocol for haploids by substituting diploid tissue with that of haploid donors. We found that cleanly grafted haploid limbs develop fully, but are smaller and shorter than the opposing diploid limbs of the same animals ([Figure 2A](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Furthermore, haploid-diploid chimeras (HDCs) exhibited a neural-GFP expression pattern similar to DDCs ([Figure 2B](#fig2){ref-type="fig"}).

![Haploid-diploid chimeric axolotl.\
(**A**) Composite fluorescent image of a chimeric axolotl produced from a limb bud graft from an RFP+ haploid embryo to a GFP+ diploid host. Scale bar = 1 cm. (**B**) Composite fluorescent image of haploid (left) and diploid (right) limbs produced by embryonic limb bud grafting from a *white* donor embryo to a GFP+ diploid host. Both the GFP- haploid limb and GFP- diploid limb grafted to a GFP+ diploid host exhibit a GFP expression pattern that appears to be restricted to spinal nerves innervating the limb (yellow arrow) and individual sensory neurons and blood-derived cells (white arrows) stemming from the host body. Blue box is at 4x magnification (bottom right). Scale bars = 1 mm. Composite images were generated by manually compiling individual photos. Images have been adjusted with cropping, contrast, color correction, and gamma correction.\
Figure 2---source data 1.The number of diploid *white* to diploid GFP+ grafts that were performed to determine the optimal embryonic stage for limb bud grafting.](elife-48511-fig2){#fig2}

Next, we tested the regenerative capacity of HDC and DDC graft limbs. We amputated HDC and DDC limbs and found that both fully regenerate and retain their neural GFP expression pattern (2/2 HDC limbs, 2/2 DDC limbs). While the gross morphology of regenerated haploid limbs is identical to that of the original limbs, haploid limb regeneration is slightly delayed relative to diploid limb regeneration ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). To quantify the fidelity of haploid limb regeneration, we generated HDCs using haploid donors mutagenized at one of two genomic loci non-essential for regeneration, *tyrosinase* and *methyltransferase-like,* for which we had previously observed faithful recapitulation of mutant allele frequencies between original and regenerated diploid limbs. NGS of targeted loci in 12 HDCs mutagenized with one of two highly active guide RNAs (gRNAs) revealed 92 total alleles with a mean mutation frequency of 3.46% per allele in the primary limbs (SE = + /- 1.19%). NGS of these targeted sites in DNA from regenerated limbs revealed that the log score of the normalized read numbers for each allele in the primary limbs predicts the log score of the normalized read numbers in the secondary limbs (R^2^ = 0.544, p\<0.0001, [Figure 3A,B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), which is similar to observations made with these same targets in diploid mosaic limbs ([@bib11]). Thus, with respect to morphology and cell lineage contributions, haploid limb regeneration is similar to that of diploid limb regeneration.

![Control alleles.\
(**A**) Comparison of all alleles generated in the controls (*methyltransferase* plus *tyrosinase*) in the original and regenerated haploid limbs of 12 animals. The log scores of the reads per ten thousand (RP10K) of every allele in the original limb are significantly correlated with those of the secondary limb (R^2^ = 0.544, p-value\<0.0001). (**B**) Linear regression comparing the log scores of RP10K for alleles depicted in 3A, but separated by gene (*methyltransferase-like* in red and *tyrosinase* in blue). The slopes of the regression lines are not significantly different for the two genes (*methyltransferase-like m* = 0.740, *tyrosinase m =* 0.935, p-value=0.238, ANCOVA).](elife-48511-fig3){#fig3}

The majority of *tyrosinase* and *methyltransferase-like* alleles (76.1%, 70/92) are detected in both the first and second haploid limbs. Most mutant alleles occur at a low frequency, comprising fewer than 1.6% of the total reads for a given haploid limb (81.5%, 75/92, [Table 1](#table1){ref-type="table"}). The majority of low-frequency alleles are detected in both primary and secondary limbs (70.7%, 53/75) and undergo less than a two-fold change in frequency after regeneration (69.3%, 52/75, [Table 1](#table1){ref-type="table"}, [Figure 3---figure supplement 2A--D](#fig3s2){ref-type="fig"}). Collectively, these results support the notion that, as in diploids, haploid limb regeneration is a high-fidelity process in which the majority of small cell lineages contribute to the regenerated limb in a manner similar to their contributions to the original developed limb.

###### The numbers of all alleles in the first limbs of controls, all targets, *fetuin-b*, all targets excluding *fetuin-b, catalase,* and all targets excluding *catalase* that are sorted by mutation frequency and log of fold change.

  Controls                  All targets                                                                                                      
  ------------------------- ----------------------------------- ------------------ ------------------------- ------------------- ------ ---- ----
  Allele Frequency          Log of fold change                  Allele Frequency   Log of fold change                                        
  (Low) Frequency \< 1.6%   \< 2                                \> 2               (Low) Frequency \< 1.6%   \< 2                \> 2        
  Alleles Lost              22                                  5                  17                        Alleles Lost        60     24   36
  Alleles Preserved         53                                  35                 18                        Alleles Preserved   94     71   23
  Sum                       75                                  40                 35                        Sum                 154    95   59
  Allele Frequency          Log of fold change                  Allele Frequency   Log of fold change                                        
  Frequency \> 1.6%         \< 2                                \> 2               Frequency \> 1.6%         \< 2                \> 2        
  Alleles Lost              0                                   0                  0                         Alleles Lost        2      0    2
  Alleles Preserved         17                                  15                 2                         Alleles Preserved   20     13   7
  Sum                       17                                  15                 2                         Sum                 22     13   9
  Total alleles: 92         Total alleles: 176                                                                                               
  *fetuin-b*                All targets except fetuin-b                                                                                      
  Allele Frequency          Log of fold change                  Allele Frequency   Log of fold change                                        
  (Low) Frequency \< 1.6%   \< 2                                \> 2               (Low) Frequency \< 1.6%   \< 2                \> 2        
  Alleles Lost              20                                  9                  11                        Alleles Lost        40     15   25
  Alleles Preserved         25                                  21                 4                         Alleles Preserved   69     50   19
  Sum                       45                                  30                 15                        Sum                 109    65   44
  Allele Frequency          Log of fold change                  Allele Frequency   Log of fold change                                        
  Frequency \> 1.6%         \< 2                                \> 2               Frequency \> 1.6%         \< 2                \> 2        
  Alleles Lost              2                                   0                  2                         Alleles Lost        0      0    0
  Alleles Preserved         1                                   0                  1                         Alleles Preserved   19     13   6
  Sum                       3                                   0                  3                         Sum                 19     13   6
  Total alleles: 48         Total alleles: 128                                                                                               
  *catalase*                All other targets except catalase                                                                                
  Allele Frequency          Log of fold change                  Allele Frequency   Log of fold change                                        
  (Low) Frequency \< 1.6%   \< 2                                \> 2               (Low) Frequency \< 1.6%   \< 2                \> 2        
  Alleles Lost              6                                   1                  5                         Alleles Lost        54     23   31
  Alleles Preserved         1                                   1                  0                         Alleles Preserved   93     70   23
  Sum                       7                                   2                  5                         Sum                 147    93   54
  Allele Frequency          Log of fold change                  Allele Frequency   Log of fold change                                        
  Frequency \> 1.6%         \< 2                                \> 2               Frequency \> 1.6%         \< 2                \> 2        
  Alleles Lost              0                                   0                  0                         Alleles Lost        2      0    2
  Alleles Preserved         1                                   0                  1                         Alleles Preserved   19     13   6
  Sum                       1                                   0                  1                         Sum                 21     13   8
  Total alleles: 8          Total alleles: 168                                                                                               

![Fetuin-b alleles compared to all other target gene and control alleles.\
(**A**) Linear regression plot of the log~2~(RP10K) score for all alleles of *fetuin-b* detected in the first and regenerated haploid limbs of 11 animals. The log scores of alleles in the primary limb poorly predict the log scores of alleles in the secondary limb. (R^2^ = 0.069, p-value=0.046). (**B**) Linear regression plot of the log~2~(RP10K) score for all alleles of all targets detected in the primary and regenerated limb (R^2^ = 0.264, p\<0.0001). (**C**) Comparison of linear regression plots of *fetuin-b* (pink) with controls (gray). The slopes of the regression lines are significantly different (*fetuin-b m* = 0.254, *controls m =* 0.861, p-value\<0.0001, ANCOVA). (**D**) Comparison of linear regression plots of *fetuin-b* (pink) with all other targets (green). The slopes of the regression lines are significantly different (*fetuin-b m* = 0.254, *all other targets m =* 0.619, p-value=0.009, ANCOVA).\
Figure 4---source data 1.Raw number of reads, normalized reads, and log~2~(RP10K) score for all mutant alleles of every targeted gene in each mutant limb in this study.](elife-48511-fig4){#fig4}

We found two genes, *fetuin-b* and *catalase,* that exhibited signs of negative selection, showing both a loss of mutant alleles and a decline in the contribution of mutant alleles from primary to secondary limbs ([Table 1](#table1){ref-type="table"}). We compared the linear regression line slopes of all mutant alleles between primary and secondary limbs for each target gene with those of the inessential controls (*methyltransferase-like* and *tyrosinase*) and found that *fetuin-b* (*fetub*) was significantly different (n = 48 mutant alleles, *fetub m* = 0.254, controls *m* = 0.861, p\<0.0001, [Figure 4A,C](#fig4){ref-type="fig"}). Further comparison of *fetub* with all other target genes combined reveals that the slope of the linear regression of *fetub* is lower than that of all other target genes combined (*fetub m = 0.*254, All other target genes *m* = 0.619, p=0.009, ANCOVA, [Figure 4D](#fig4){ref-type="fig"}). Linear regression analysis of *fetub* reveals that the log scores of the normalized read numbers for each allele in the second limb poorly predict the log scores of the normalized read numbers in the primary limb (R^2^ = 0.069, p=0.046, [Figure 4A](#fig4){ref-type="fig"}). Alleles of *fetub* detected in the primary limb are more likely to be absent in the secondary limb (45.8%, 22/48) than alleles detected in controls (23.9%, 22/92) and this difference is significant (χ^2^ = 7.03, p=0.008). *Fetub* alleles (45.8%, 22/48) are more likely to be absent from the second limb than alleles of all other targets combined (31.3%, 40/128), but this effect is not significant, except when the other outlier, *catalase,* is excluded (χ^2^ = 3.25, p=0.071 and χ^2^ = 5.23, p=0.022, respectively).

Similarly, the slope of the linear regression of *catalase* alleles differed from control genes (n = 8 mutant alleles, *catalase m* = 0.018, controls *m* = 0.861, p=0.005, ANCOVA, [Figure 5A,C](#fig5){ref-type="fig"}). The slope of the linear regression of *catalase* did not differ from that of all other target genes combined, except when *fetub* was excluded (*catalase m* = 0.018, all other target genes *m* = 0.550, p=0.073, all other target genes excluding *fetub m* = 0.645, p=0.029, ANCOVA, [Figure 5B,D](#fig5){ref-type="fig"}). A significantly greater proportion of *catalase* alleles are lost (75.5%, 6/8) than both those of controls and all other targets combined (χ^2^ = 9.53, p=0.002 and χ^2^ = 5.81, p=0.016, respectively).

![Catalase alleles compared to all other target gene and control alleles.\
(**A**) Linear regression plot of the log~2~(RP10K) score for all alleles of *catalase* detected in the first and regenerated haploid limbs of three animals. The log scores of alleles in the primary limbs do not predict the log scores of alleles in the secondary limbs. (R^2^ = 0.002, p-value=0.898). (**B**) Comparison of linear regression plots of *catalase* (red) with all other targets excluding *fetuin-b* (teal). The slopes of the regression lines are significantly different (*catalase m* = 0.018, all other targets excluding *fetuin-b m =* 0.645, p-value=0.029, ANCOVA). (**C**) Comparison of linear regression plots of *catalase* (red) with controls (gray). The slopes of the regression lines are significantly different (*catalase m* = 0.018, *controls m =* 0.861, p-value=0.005). (**D**) Comparison of linear regression plots of *catalase* (red) with all other targets (green). The slopes of the regression lines are not significantly different (*catalase m* = 0.018, all other targets *m =* 0.550, p-value=0.073, ANCOVA).](elife-48511-fig5){#fig5}

To increase the total number of *catalase *and* fetub *mutants analyzed, we next addressed whether loss of these genes perturbs regeneration at a whole organismal level. We produced early embryonic mutants for *catalase, fetub*, and *tyrosinase* by injecting gRNAs against each with Cas9 protein into zygotes. At stage 44, we amputated the posterior 2 mm of the tails of each larva and monitored its regeneration. We extracted DNA from the amputated tails and confirmed the high-level mutagenesis of *fetub* and *catalase* by fluorescent PCR fragment analysis (*fetub*, n = 12, mean = 7.3% wildtype alleles, SD = + /- 5.2%;. *catalase*, n = 16, mean = 3.0% wildtype alleles, SD = + /- 5.8%, [Figure 6---source data 1](#fig6sdata1){ref-type="supplementary-material"}). *fetub* and *catalase* mutants did not display regeneration growth defects compared to *tyrosinase* mutants at early time points, but the total regenerative outgrowth of both *fetub* and *catalase* mutant tails were reduced compared to *tyrosinase* mutants at 18 days post-amputation (n = 16 *tyrosinase* mutants, p=0.002, *fetub*; p=0.012, *catalase*; Welch's t-test, one-tailed; [Figure 6A--C](#fig6){ref-type="fig"}), with the reduction in regeneration also evident at 14 days post-amputation in *catalase* mutant tails (p=0. 025, Welch's t-test, one-tailed, [Figure 6A](#fig6){ref-type="fig"}). These data indicate that, while *catalase* and *fetub* are not essential for the onset of regeneration, the process of regeneration is slower in the tails of *catalase* and *fetub* mutants. These findings are consistent with the apparent loss of catalase and *fetub* mutant cells within the context of regenerating mosaic mutant haploid limbs and suggest a broader role for these genes in the regeneration of multiple tissues and structures. As cell competition in developing tissues can result in the elimination of cells lacking genes controlling the rate of growth at a whole organismal level ([@bib19]; [@bib28]), these findings support the validity of this assay as a means to identify genes critical for proper regeneration.

![Larval tail regeneration in tyrosinase, catalase, and fetuin-b mutants.\
(**A**) Regenerative outgrowth of tail in high-level *tyrosinase, catalase,* and *fetuin-b* F~0~ mutants. While no significant difference is detected at early time points, both *fetuin-b* and *catalase* mutants display tail reduced tail regeneration compared to *tyrosinase* mutants at later time points (*catalase* vs *tyrosinase,* Day 4, p=0.205, Day 6, p=0.400, Day 10, p=0.111. Day 14, p=0.026, Day 18, p=0.011; *fetuin-b* vs *tyrosinase,* Day 4, p=0.450, Day 6, p=0.129, Day 10, p=0.047, Day 14, p=0.109, Day 18, 0 = 0.002, Welch's t-test). Bars indicate standard deviation. (**B**) Plots of lengths of regenerate in individual *tyrosinase, catalase,* and *fetuin-b* F~0~ mutants at 18 days post-amputation; \*\*=*fetuin* b, p=0.002, *\*=catalase,* p=0.011. (**C**) Brightfield images of individual *tyrosinase, catalase,* and *fetuin-b* F~0~ mutants at 18 days post-amputation (dpa) showing median amount of tail regeneration at 18 dpa. Dotted line indicates the amputation plane.\
Figure 6---source data 1.Regenerative outgrowth measurements and genotyping data for *tyrosinase*, *catalase,* and *fetuin-b* F~0~ mutants.](elife-48511-fig6){#fig6}

Discussion {#s3}
==========

Collectively, our data suggests that cells lacking the limb blastema-enriched genes, *fetub* and *catalase*, have a reduced capacity to contribute to the regenerating limb. *Catalase* is an enzyme that plays a conserved role in protecting cells from oxidative damage by catalyzing the decomposition of hydrogen peroxide, a reactive oxygen species (ROS). Despite their potentially harmful effects, ROS are critical for normal tail, fin, and heart regeneration to proceed in *xenopus* and zebrafish ([@bib24]; [@bib14]; [@bib16]). However, prolonged ROS-exposure and ROS-induced cellular senescence impair tissue regeneration ([@bib32]). Overexpression of *catalase* impedes heart regeneration after infarction in zebrafish, and chemical inhibition of Catalase may transiently delay tail regeneration in *xenopus* larva, suggesting that ROS levels must be carefully regulated during regeneration ([@bib16]; [@bib40]).

*Fetuin-B* and its paralogue *Fetuin-A,* are highly expressed in the liver, where they are secreted into the blood plasma, and are also expressed in the chondrocytes and muscle cells of developing limb buds in mouse, rat, and sheep ([@bib38]; [@bib31]; [@bib7]; [@bib5]). Mammalian Fetuins belong to the cystatin superfamily of proteins, which include many protease inhibitors, yet these two proteins appear to have differing biochemical activities ([@bib5]; [@bib20]). *Fetuin-A* is expressed in the growth plate chondrocytes of young mice and is required for proper long bone development, and *Fetuin-A k*nockout mice exhibit severely foreshortened femora due to growth plate deformations and displaced distal epiphyses ([@bib34]). *Fetub,* knockout mice, however, do not display these defects, and instead show female infertility ([@bib6]); and mammalian Fetuin-B, unlike Fetuin-A, appears to function as a specific inhibitor of meprin and ovastacin metalloproteinases ([@bib20]). Extracellular matrix remodeling by metalloproteinases is crucial for a variety of processes, including regeneration. Together, our results suggest that locally expressed Fetub is an important regulator of regeneration in the axolotl.

Both genes for which mutant cells exhibited negative selection in this assay are not developmentally essential in mice; however, transcriptional profiling of axolotl limb blastemas across the time course of regeneration indicates that a considerable portion of blastema-enriched genes are known to participate in limb development or cell survival in other organisms ([@bib27]; [@bib21]; [@bib37]). We anticipate that mosaic loss-of-function of many genes enriched in both the limb bud and limb blastema may result in a depletion of mutant cell lineages prior to limb formation. Thus, mutant alleles of genes required for both limb development and regeneration may not exhibit negative selection in this assay. Exclusion of mutant alleles prior to limb formation may potentially be investigated by comparing allele frequencies from targeted loci in non-grafted tissues in donor haploid embryos to those found within developed limbs arising from tissue grafts from the same embryos. The identification and validation of *catalase* and *fetub* in this assay suggests that this method is particularly useful for identifying genes that are not essential for limb development but critical for proper regeneration.

Recent single-cell analyses of blastema cells across the time course of regeneration indicate that connective-tissue-derived blastema cells transcriptionally converge to express a shared set of genes distinct from that expressed in developing limb buds; however, at later stages of regeneration these blastema cells recapitulate transcriptional programs found in developing limbs ([@bib15]). These findings indicate that the genes controlling early blastema formation do not substantially overlap with those required for proper limb development. There are several known examples demonstrating dissociation between the genetic control of limb of development and regeneration in the axolotl. The long-characterized recessive short-toes allele in axolotls produces animals that develop limbs but display a progressive decline in regenerative capacity ([@bib4]; [@bib13]). Similarly, loss of *sox2* in axolotls produces an early spinal cord regeneration defect without perturbing spinal cord development ([@bib8]). Nonetheless, because of the potential confounding effects that may arise in this assay when targeting genes essential for limb development, we largely excluded blastema-enriched genes expected to be required for limb development from the set of targeted genes in this study.

Although this negative selection assay in mosaic haploid mutant limbs led to the identification and subsequent confirmation of *catalase* and *fetub* as critical regeneration genes, we failed to detect significant evidence of negative selection of mutant alleles for other assessed candidate genes. For several of these targeted genes, there were insufficient mutant alleles to provide evidence of negative selection ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). The absence of significant negative selection for these targets should not be regarded as evidence that these genes are not critical for limb regeneration. As we conducted multiplex mutagenesis to permit analysis of multiple targets in limbs of an individual animal, we reduced the mass of injected gRNAs from that used in earlier CRISPR mutagenesis studies ([@bib11]) to prevent confounding effects caused by mutating multiple targets in single-cell lineages. While 16/25 gRNAs used in this study produced mutant alleles in the limb of at least one animal analyzed, we expect that in future studies injecting greater quantities of gRNA will produce more mutant alleles without confounding results.

Here, we provide a novel screening platform that couples targeted mutagenesis and lineage tracing to identify novel regulators of regeneration. This method relies upon the ability to generate chimeric animals that possess mutagenized haploid limbs. We find that the development and regeneration of these haploid limbs is comparable to that of diploid limbs. Using this approach, we find that *catalase* and *fetuin-b* are required for cells to participate in limb regeneration and for proper tail regeneration. As the axolotl possesses an impressive capacity to regenerate many parts of its body, future work should explore whether haploid chimeric approaches may be applied to the study the regeneration of these structures. To our knowledge, this is the first example of a true in vivo haploid selection screen conducted in a complex structure of a vertebrate.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                             Designation                                Source or reference                  Identifiers                                                                              Additional\
  (species) or resource                                                                                                                                                                                              information
  ----------------------------------------- ------------------------------------------ ------------------------------------ ---------------------------------------------------------------------------------------- --------------------------
  Genetic reagent (*Ambystoma mexicanum*)   *cagg:egfp*                                Ambystoma Genetic\                   AGSC Cat\# 110A, RRID:[AGSC_110A](https://scicrunch.org/resolver/AGSC_110A)              
                                                                                       Stock Center\                                                                                                                 
                                                                                       ([@bib36])                                                                                                                    

  Genetic reagent (*Ambystoma mexicanum*)   *cagg:nls-mcherry*                         Ambystoma Genetic Stock Center\      AGSC Cat\# 112A, RRID:[AGSC_112A](https://scicrunch.org/resolver/AGSC_112A)              
                                                                                       ([@bib22])                                                                                                                    

  Chemical compound, drug                   MS-222                                     Western Chemical                     ANADA \#200--226                                                                         

  Chemical compound, drug                   Human chorionic gonadotropin (Chorulon,)   Merck Animal Health                  NADA 140--927                                                                            

  Gene (*Ambystoma mexicanum*)              *msx2*                                     Axolotl transcriptome assembly 3.4   [AMEXTC_0340000067092](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000067092)   

  Gene (*Ambystoma mexicanum*)              *prmt1*                                    Axolotl transcriptome assembly 3.4   [AMEXTC_0340000062704](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000062704)   

  Gene (*Ambystoma mexicanum*)              *myl6*                                     Axolotl transcriptome assembly 3.4   [AMEXTC_0340000067862](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000067862)   

  Gene (*Ambystoma mexicanum*)              *fetub*                                    Axolotl transcriptome assembly 3.4   [AMEXTC_0340000227254](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000227254)   

  Gene (*Ambystoma mexicanum*)              *hoxc8*                                    Axolotl transcriptome assembly 3.4   [AMEXTC_0340000065333](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000065333)   

  Gene (*Ambystoma mexicanum*)              *akap8l*                                   Axolotl transcriptome assembly 3.4   [AMEXTC_0340000192860](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000192860)   

  Gene (*Ambystoma mexicanum*)              *hrnrpa0*                                  Axolotl transcriptome assembly 3.4   [AMEXTC_0340000081837](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000081837)   

  Gene (*Ambystoma mexicanum*)              *hsd17b10*                                 Axolotl transcriptome assembly 3.4   [AMEXTC_0340000257015](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000257015)   

  Gene\                                     *hoxb9*                                    Axolotl transcriptome assembly 3.4   [AMEXTC_0340000035333](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000035333)   
  (*Ambystoma mexicanum*)                                                                                                                                                                                            

  Gene (*Ambystoma mexicanum*)              *tyrosinase*                               Axolotl transcriptome assembly 3.4   [AMEXTC_0340000179254](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000179254)   

  Gene (*Ambystoma mexicanum*)              *etv4*                                     Axolotl transcriptome assembly 3.4   [AMEXTC_0340000233035](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000233035)   

  Gene (*Ambystoma mexicanum*)              *cacng1*                                   Axolotl transcriptome assembly 3.4   [AMEXTC_0340000081988](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000081988)   

  Gene (*Ambystoma mexicanum*)              *catalase*                                 Axolotl transcriptome assembly 3.4   [AMEXTC_0340000186723](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000186723)   

  Gene (*Ambystoma mexicanum*)              *hoxb13*                                   Axolotl transcriptome assembly 3.4   [AMEXTC_0340000007929](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000007929)   

  Gene (*Ambystoma mexicanum*)              *zic5*                                     Axolotl transcriptome assembly 3.4   [AMEXTC_0340000057641](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000057641)   

  Gene (*Ambystoma mexicanum*)              *ecm1*                                     Axolotl transcriptome assembly 3.4   [AMEXTC_0340000123229](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000123229)   

  Gene (*Ambystoma mexicanum*)              *cornifelin*                               Axolotl transcriptome assembly 3.4   [AMEXTC_0340000173184](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000173184)   

  Gene (*Ambystoma mexicanum*)              *dsg-like*                                 Axolotl transcriptome assembly 3.4   [AMEXTC_0340000056512](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000056512)   

  Gene (*Ambystoma mexicanum*)              *enpp2*                                    Axolotl transcriptome assembly 3.4   [AMEXTC_0340000217071](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000217071)   

  Gene (*Ambystoma mexicanum*)              *fabp2*                                    Axolotl transcriptome assembly 3.4   [AMEXTC_0340000084459](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000084459)   

  Gene (*Ambystoma mexicanum*)              *pmp2*                                     Axolotl transcriptome assembly 3.4   [AMEXTC_0340000238807](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000238807)   

  Gene (*Ambystoma mexicanum*)              *kcne1*                                    Axolotl transcriptome assembly 3.4   [AMEXTC_0340000121776](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000121776)   

  Gene (*Ambystoma mexicanum*)              *krt6a*                                    Axolotl transcriptome assembly 3.4   [AMEXTC_0340000060835](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000060835)   

  Gene (*Ambystoma mexicanum*)              *rcc1*                                     Axolotl transcriptome assembly 3.4   [AMEXTC_0340000210022](https://www.axolotl-omics.org/transcripts/AMEXTC_0340000210022)   

  Recombinant DNA reagent                   MLM3613                                    ([@bib18])                           RRID: [Addgene](https://scicrunch.org/resolver/Addgene_42251) plasmid 42251              *Cas9* expression vector

  Peptide, recombinant protein              Cas9                                       PNABio                               Cat. \#: CP04-500                                                                        

  Commercial assay or kit                   mMessage mMachine Kit                      ThermoFisher                         Cat. \#: Am1345                                                                          

  Commercial assay or kit                   MAXIscript SP6/T7 Transcription Kit        ThermoFisher                         Cat. \#: Am1322                                                                          

  Chemical compound, drug                   MS-222                                     Sigma Aldrich                        SML1656                                                                                  

  Software, algorithm                       Geneious Software                          Biomatters                           RRID:[SCR_010519](https://scicrunch.org/resolver/SCR_010519)                             
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Animals {#s4-1}
-------

All animal experiments were carried out on *Ambystoma mexicanum* (axolotls) in facilities at Yale University. Experimental procedures were approved by the Yale University IACUC (2017--10557) and were in accordance with all federal policies and guidelines governing the use of vertebrate animals. All axolotls used in this study were produced by natural mating or in vitro fertilization and housed in our facility. They were fed artemia, blood worms, and fish pellets. The parental *cagg:egfp* and *cagg:nls-mcherry* transgenic animals were originally obtained from the Ambystoma Genetic Stock Center ([@bib22]; [@bib36]).

Haploid generation {#s4-2}
------------------

Gametes were collected in a manner similar to that previously described ([@bib25]), and haploids were generated using in vitro activation methods ([@bib39]). RFP+ or white mutant females were anesthetized in 1 g/L MS-222 (Tricaine-S, Western Chemical) and injected with 1500 units of human chorionic gonadotropin (Chorulon, Merck Animal Health) in the dorsal musculature above the hind limbs. Females were stored at 8°C to 10°C for 2 days until they began laying unfertilized eggs. Gametes were then collected from a GFP+ male by gentle pelvic squeezing using a P1000 micropipette. Sperm viability and concentration was assessed using an inverted microscope. Sperm was diluted to 80,000 motile cells/mL in sterile 0.1x MMR and spread on a sterile petri dish to form a 1-mm deep film. Eggs were extracted from the female after full anesthesia in a similar manner, without the use of a pipette. To enucleate, sperm were placed 4 cm from the bulbs of a 254 nm CL-1000 Ultraviolet Crosslinker (UVP) and irradiated with 800,000 uJ/mm^2^ of UV energy. Each unfertilized egg was then coated with 0.25 to 0.5 µL of enucleated sperm and allowed to sit at room temperature for 30 min. Eggs were then flooded with sterile 0.1x MMR. Haploid embryos were individually housed and maintained from 10°C to 18°C. Haploids were inspected for GFP expression 3 to 4 days after in vitro activation.

Karyotype analysis {#s4-3}
------------------

Stage 35 embryos selected for karyotype analysis were staged according to the Schreckenberg and Jacobson staging series ([@bib33]). Embryos were prepared for karyotype analysis by incubating them in 0.25% colchicine in 0.1x MMR for 48 hr at 18°﻿. Embryos were then washed twice with dissociation solution (0.1x MMR without Ca^2+^ or Mg^2+^) with 0.25% Colchicine. Using fine forceps, the ventral half of each embryo was removed and individually transferred to a microcentrifuge tube containing 1 mL of dissociation solution and incubated at room temperature for 5 min. Using a Pasteur pipette, cells were loosened by gentle agitation and allowed to settle. All but 50 µL of the dissociation solution was removed without disturbing the cells and replaced with 950 L of 60% acetic acid in water, gently mixed, and allowed to stand for 5 min. The fixed cells were pipetted onto positively charged slides, which were briefly flamed to dry before a cover slip was added. Without disturbing the coverslip, a 50-lb lead brick with a paper towel cushion was placed on the slide to squash the cells. After 5 min, the brick was removed, the slides frozen on dry ice, and the coverslips were pried off with a scalpel. The samples were then stained with Hoechst 33342, covered, and sealed with clear nail polish.

Genome editing {#s4-4}
--------------

Target gRNA sequences are listed in the [Supplementary file 1](#supp1){ref-type="supplementary-material"}. Axolotl matings and microinjections were carried out as previously described ([@bib12]) with the following modifications for haploid mutagenesis: Haploids were allowed to develop for 7 hr until they reached a two-cell stage. For multiplex mutagenesis, each blastomere was injected with an equal volume of injection mix for a total of 1000 pg of *cas9* mRNA and 5 pg per gRNA (five total). Each gRNA was injected in two separate pools of gRNAs into embryos from two separate matings. Control embryos were injected as described, but with 50 pg of gRNA. The data described represents the results from ten independent in vitro fertilization, injection, and grafting experiments to produce experimental animals, and three additional experiments to produce control animals.

For tail regeneration experiments, embryos were produced by a single mating and injected with 1250 pg of gRNA coupled with 1250 pg of Cas9 protein (PNA Bio) as described previously within 2 hr of being laid ([@bib9]). Successful mutagenesis of *tyrosinase* was assessed by loss of pigmentation. Mutations of *catalase* and *fetuin-b* were confirmed by fragment analysis PCR ([Figure 6---source data 1](#fig6sdata1){ref-type="supplementary-material"}).

Limb field grafting {#s4-5}
-------------------

Stage-matched haploid embryos and GFP+ diploid hosts (stages 21--25) were freed from their vitelline membranes and washed with sterile 0.1x MMR with antibiotics and stored overnight at 4°C. The embryos were then transferred to refrigerated, sterile agar plates with holding grooves and maintained at 8°C on a chilled-stage dissecting microscope. Two sets of Dumostar forceps (Dumont \#55, Fine Science Tools) were used to replace the limb bud fields from the GFP hosts with the corresponding tissue from haploid donors. Tissue grafts were held in place for one hour using a small rectangular glass shard from a crushed cover slip. The glass shards were then carefully removed, and the embryos were gently transferred to individual housing at 12°C for 24 hr. Afterwards, the embryos were transferred to new sterile 0.1x MMR with antibiotics and maintained at 16°C to 18°C. 0.1x MMR was replaced every day until the tadpoles began to feed. After 2 to 3 months of development, limbs were inspected for purity and quality using a fluorescent dissecting microscope.

Amputations {#s4-6}
-----------

Amputations were performed through the mid-zeugopod as previously described ([@bib11]). Animals were anesthetized in 1 g/L MS-222 (Tricaine-S, Western Chemical). For each gRNA target pool, an additional amputation was performed on a non-mutant animal to serve as a non-mutant control for sequencing. Limbs were frozen at −20° C until all primary and secondary limbs were collected.

Tail amputations were carried out in stage 44 larvae ([@bib29]). Larvae were maintained at 19.5°C in 0.1x MMR. Embryos were monitored and imaged with a Zeiss stereomicroscope using brightfield imaging.

Genomic DNA preparation {#s4-7}
-----------------------

Genomic DNA was extracted from entire amputated limbs using the DNeasy Blood and Tissue Collection Kit (Qiagen) according to the manufacturer's protocol with the following modifications: limbs were suspended in a 3x volume and completely digested with vortexing in Proteinase K for 6 to 8 hr at 56°C. Before adding AL buffer and ethanol, the digest was split into three separate tubes of equal volume for each limb and treated as a separate sample. After the addition of AL buffer and ethanol, the sample was vortexed and frozen at −20°C overnight. After thawing, the purification process was completed according to the manufacturer's instructions. For tail amputations, DNA was extracted from 2 mm tissue samples using the QiaAmp DNA Kit (Qiagen) according to the manufacturer's instructions.

Target amplification and genotyping {#s4-8}
-----------------------------------

All PCRs for primary and secondary limbs were performed at the same time using Phusion High-Fidelty DNA Polymerase (NEB). Target sequences were labeled using a three-cycle labeling step with a unique molecular identifier (UMI), purified, and amplified with final 30-cycle PCR using the purified UMI-labeled product as a template. The final PCR product was purified to remove all primers. For the three-cycle UMI labeling step, 500 ng of genomic DNA was used as template in a 100 µL reaction. For each 30-cycle PCR, an indexed universal adaptor forward primer and a gene-specific reverse primer was used. From 5' to 3', each UMI consists of a universal adaptor sequence, a 10N randomized barcode, and 18 to 28 bases of gene specific sequence. Each universal adaptor primer possesses a unique 4 to 6 bp 5' indexing sequence. For each target, this process was carried out for a no-gDNA control. All products were purified using 1.0x Ampure XP magnetic beads (Agencourt). Products were prepared for sequencing using the TruSeq Nano DNA Library Prep Kit and indexed with the Unique Dual Indexes for TruSeq (Illumina). All universal and gene specific primer sequences are listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

The mutation rate in individual larvae for tail regeneration experiments was determined using fragment analysis of fluorescent PCR products as described previously ([@bib12]) and analyzed using GeneMapper software. (Thermo Fisher Scientific). Animals in which PCR fragments corresponding to the expected size of wildtype PCR products represented more than 15% of the total intensity of the sum of all PCR products were excluded from analysis.

Amplicon library QC {#s4-9}
-------------------

To identify and size the various amplicon products in each sample, libraries were analyzed on the Agilent TapeStation 4200 (Agilent Technologies) using the DNA D1000 High Sensitivity assay. Target peaks were identified within the range of 150 bp -- 500 bp and samples were then processed for upper and lower automated size selection using the Pippin Prep 2% Agarose, dye-free cassette (Sage Science). Size selected eluates were purified using the Qiagen PCR purification kit (Qiagen) and re-analyzed on the Agilent Tapestation DNA D1000 High Sensitivity assay to confirm the removal of products less than 150 bp and greater than 500 bp. Amplicon libraries were then quantified and normalized using the dsDNA High Sensitivity Assay for Qubit 3.0 (Life Technologies).

Illumina MiSeq sequencing {#s4-10}
-------------------------

The sample library pools were prepared for Illumina MiSeq sequencing following the denaturing and dilution protocol set forth by the manufacturer (Illumina). Prior to MiSeq v2 500 cycle sequencing, the prepared pool was first quality checked on a MiSeq Reagent kit v2 Nano to ensure proper representation of each sample (biased pooling percentage). Deep sequencing on the MiSeq Reagent kit v2 500 cycle was performed with paired end 250 bp reads across five sequencing runs.

Sequence analysis {#s4-11}
-----------------

Alleles were quantified as previously described ([@bib11]). UMI sequences were extracted from each sequence read after allele assignment, and duplicate sequences were eliminated using the 'eliminate duplicate reads' function in Geneious R11. Based upon the input molecular weight of DNA used in our initial PCRs, we estimated that the sequence reads for each gene for each limb represents a sample of approximately 10,000 cells. We produced normalization coefficients by dividing 10,000 by the total number of unique assigned reads for each target for each animal. The number of unique reads for each allele was multiplied by this coefficient to produce a reads per 10 k (RP10K) value. To obtain coherent log scores, one was added to each value prior to log calculations. All allele sequences, raw allele counts, normalized read numbers, and log values for every animal for each gene can be found in [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}.

Statistical analyses {#s4-12}
--------------------

The log scores of normalized sequence reads for all alleles of control genes and experimental genes were compared between primary and secondary limbs. Linear regressions were created for each target and control gene, and the slope of each experimental gene regression was compared both to that of all control genes and that of all other experimental genes by one-way ANCOVA in GraphPad Prism software. As two genes were found to differ significantly from control genes, the alleles for those genes were excluded from the set of experimental genes, and the slope of each experimental gene regression was compared to the trimmed set of all other experimental genes.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

The work provides what we understand to be the first attempt towards a saturation haploid CRISPR/Cas9-based screen for mutations affecting limb/tail regeneration in axolotyl. In limb regeneration, the work has identified guild RNAs that are statistically underrepresented in engrafted tissue regenerates, and highlighted roles for catalase and fetuin-b, confirmed in a tail regenerative assay. While there are clearly limitations to the approach given its statistical basis and potentially mild phenotypes, we appreciate the effort and rigor that has brought the system to this point, and the study should represent a landmark in this field. The authors have considerably improved the manuscript and provided an independent analysis of CRISPR-generated F0 mutations in catalase and fetuin-b compared to tyrosinase controls on tail regeneration in a time course manner, finding delays not in the onset, but in progression of the regenerative process. The study provides a platform for analysis of a broader range of mutants in greater detail and for improvements in approaches with respect to methods and scale in the axolotl system, and should provide a key stimulus for others to attempt analogous screens in other regenerative systems.

**Decision letter after peer review:**

Thank you for submitting your article \"Multiplex CRISPR/Cas screen in regenerating haploid limbs of chimeric Axolotls\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Patricia Wittkopp as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The reviewers appreciated the elegance and thoughtfulness of the approach, and the preliminary data generated. The manuscript describes the first application of haploid screening in an animal model. They felt the work potentially provides an important roadmap for relatively rapid limb-specific functional analysis of genes during regeneration using CRISPR -- something that has been sorely missing in the field.

However, the following points were raised.

1\) Cells with essential regeneration genes knocked out may also be at a disadvantage in the primary transplant to initially generate chimeric animals. This is a limitation and is not discussed. It seems one would want to first target chimeric embryos, then isolate guides from limb bud grafts pre transplant and compare these guide signals to post transplant primary limbs. This would first identify genes that are essential for drop out during original limb formation. Then compare this to secondary limb to define regeneration-specific targets. Examples of where primary and regenerative limb development are under fundamentally different molecular regulation are known and should be highlighted, but in general there may be strong overlap in developmental and regenerative pathways. If so, these targets can be used as controls to establish the power and rigor of the system.

2\) Inclusion of control targets known to be essential for regeneration is critical to establish the optimal design for dropout screening in this system, and in our opinion this needs to be done before publication. With the method relying on statistical differences between recovered alleles in primary and secondary limbs, and the very apparent noise in this system, one wants to see a solid positive control essential for regeneration showing significant drop out in pools.

3\) In this study, the authors identified fetuin-b and catalase as likely undergoing negative selection but the evidence is only suggestive. To prove the power of this system, it is essential that the authors confirm these two targets are actually required in a confirmation experiment. This would be straightforward if the screen were done just with those targets. Evidence exists for a role of catalase (and ROS) in developing and regenerating organs, and the phenotypes may relate more to differential proliferation in different limb tissues which may translate to allele dropout. Based on previous work in axolotl, 100% targeting. should be possible, notwithstanding the issues of heterogeneous alleles including those introducing in-frame mutations and issue that may arise due to mosaic mutations in non-cell autonomous genes. If these two genes are essential for regeneration, and haploid KO limbs do not regenerate, then that would establish the power of this system. If they are not essential, then this shows the system needs further improvement.

Summary:

Overall there is support for this manuscript, however evidence for the technique as a compelling platform is still missing.

Essential revisions:

For the manuscript to proceed, it will be essential to provide stronger evidence for the above -- the inclusion of positive controls that end up being compellingly championed by the method and/or follow up experiments that compellingly show how candidates affect limb regeneration. We appreciate the effort involved in this. The manuscript is not sufficiently self-critical with respect to the method\'s strengths and limitations. This must also be addressed.
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Author response

> The reviewers appreciated the elegance and thoughtfulness of the approach, and the preliminary data generated. The manuscript describes the first application of haploid screening in an animal model. They felt the work potentially provides an important roadmap for relatively rapid limb-specific functional analysis of genes during regeneration using CRISPR -- something that has been sorely missing in the field.
>
> However, the following points were raised.
>
> 1\) Cells with essential regeneration genes knocked out may also be at a disadvantage in the primary transplant to initially generate chimeric animals. This is a limitation and is not discussed. It seems one would want to first target chimeric embryos, then isolate guides from limb bud grafts pre transplant and compare these guide signals to post transplant primary limbs. This would first identify genes that are essential for drop out during original limb formation. Then compare this to secondary limb to define regeneration-specific targets. Examples of where primary and regenerative limb development are under fundamentally different molecular regulation are known and should be highlighted, but in general there may be strong overlap in developmental and regenerative pathways. If so, these targets can be used as controls to establish the power and rigor of the system.

We agree with the reviewers' point that cells lacking genes essential for regeneration may also be at a disadvantage during limb development, and, thus, we may expect to see a discrepancy between allele frequencies in limb buds and mature limbs. While the time permitted for revisions was not sufficient to explore this experimentally, we have emphasized the likelihood of negative selection during limb development and suggested ways in which this may be explored. We have discussed examples in which there is a dissociation between genes essential for development and regeneration. We have cited recent single-cell transcriptomic work indicating that, prior to recapitulating developmental gene expression, blastema cells exhibit a shared transcriptional profile distinct from that of developing limbs. For these reasons, we believe that this assay is particularly useful for detecting those genes not essential for limb development but critical for proper regeneration.

> 2\) Inclusion of control targets known to be essential for regeneration is critical to establish the optimal design for dropout screening in this system, and in our opinion this needs to be done before publication. With the method relying on statistical differences between recovered alleles in primary and secondary limbs, and the very apparent noise in this system, one wants to see a solid positive control essential for regeneration showing significant drop out in pools.
>
> 3\) In this study, the authors identified fetuin-b and catalase as likely undergoing negative selection but the evidence is only suggestive. To prove the power of this system, it is essential that the authors confirm these two targets are actually required in a confirmation experiment. This would be straightforward if the screen were done just with those targets. Evidence exists for a role of catalase (and ROS) in developing and regenerating organs, and the phenotypes may relate more to differential proliferation in different limb tissues which may translate to allele dropout. Based on previous work in axolotl, 100% targeting. should be possible, notwithstanding the issues of heterogeneous alleles including those introducing in-frame mutations and issue that may arise due to mosaic mutations in non-cell autonomous genes. If these two genes are essential for regeneration, and haploid KO limbs do not regenerate, then that would establish the power of this system. If they are not essential, then this shows the system needs further improvement.

As agreed upon in our previous correspondence with the editor, we generated high-mutation-rate F0 animals with Cas9 protein, amputated their larval tail tips, and monitored tail regeneration. We genotyped these *fetuin-b* and *catalase* mutants to identify those in which mutation rates at the targeted sites were greater than 80% and compared their regeneration to that of control siblings in which the control gene *tyrosinase* had been targeted (loss of *tyrosinase* provided a visual means to confirm successful mutagenesis). We found that *fetuin-b* and *catalase* mutants have impaired tail regeneration, as their tail tips were significantly shorter than that of their *tyrosinase-*mutant siblings. In the absence of well-characterized control genes that could be used for this study, the confirmation of regeneration defects in mutants for both genes that exhibited significant negative selection in regenerated haploid limbs supports the validity of the described approach.

[^1]: These authors contributed equally to this work.
